Status:
COMPLETED
China Salt Substitute Study in Tibet
Lead Sponsor:
The George Institute for Global Health, China
Collaborating Sponsors:
Peking University
Beijing Jishuitan Hospital
Conditions:
Hypertension
Eligibility:
All Genders
40+ years
Phase:
NA
Brief Summary
The study was a single-blind randomized controlled trial conducted between February and August 2009 in two townships (Yangbajing and Gongtang) of Dangxiong County, an area at 4300 meters altitude in T...
Detailed Description
Hypertension is one of the most important risk factors that induce cardiovascular and cerebrovascular disease. Reducing the blood pressure levels of population can not only control the incidence of ca...
Eligibility Criteria
Inclusion
- Age 40 years or older
- Resident of Yangbajing Township and Gongtang Village in Tibetan Autonomous Region, People's Republic of China
- Mean Systolic Hypertension (≥ 140 mmHg)
Exclusion
- Currently taking any potassium supplements (or lives in household where someone does)
- Previously diagnosed kidney disease or gout (or lives in a household where someone does) and physician considered he/she cannot take salt substitute.
- Any person who intended to use salt outside the assigned treatment salt provide in the study
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
282 Patients enrolled
Trial Details
Trial ID
NCT01429246
Start Date
February 1 2009
End Date
August 1 2009
Last Update
July 29 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dangxiong People's Hospital
Lhasa, Tibet, China, 850000